Team |
Kate Zulauf, PhD
Kate Zulauf, PhD

Kate Zulauf, PhD

Scientist II

Technology Development

Kate’s work on the Technology Development team focuses on developing base editing therapeutics.

Prior to joining Life Edit, Kate worked at Locus Biosciences where she engineered phage with Type I CRISPR systems as a novel antibacterial therapeutic.

Kate completed a postdoctoral fellowship at Beth Israel Deaconess Medical Center/Harvard Medical school where she identified small molecule inhibitors of plasmid maintenance in drug resistant bacterial strains. She received her PhD in Microbiology and Immunology at the University of North at Chapel Hill where she studied protein secretion and host-pathogen interactions of Mycobacterium tuberculosis.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.